This article addresses two general topics. First, we provide an overview of the National 
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Specific tests can be requested and inquiries can be made from links at www.mmpc.org.
78
The investigator will be contacted by a center, receive an estimate for the service(s) and given 79 information for shipping of mice or samples. Data are sent directly to the investigator.
80
Investigators may also contact centers directly using the contact information listed at 81 www.mmpc.org. 
95
is in place to protect the interests of investigators. All data and intellectual property that are 96 generated by the MMPC belong to the investigator that has submitted the request for services.
97
NIH requests that investigators allow data generated by an MMPC to be placed in the public
98
MMPC database after one of the following two conditions has been met: 1) the data have been 99 published and are therefore in the public domain or 2) two years have passed since completion 100 of services by the MMPC. Investigators may request that specific data be withheld from the 101 public database for an additional period of time.
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The capacity to make multiple measurements in a single mouse allows for more precise 
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Mouse is limited to 10 participants due to the laboratory nature of the course.
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In 2007 
Evaluating Glucose Homeostasis in the Mouse

148
The interpretation of data is dependent on issues of experimental design. In this section
149
we address some observations regarding commonly used tools to test glucose tolerance and 
153
A primary screen to evaluate whether a genetic manipulation alters glucose homoeostasis 154 is the measurement of fed and fasting circulating glucose and insulin. One of the difficulties 155 inherent in this is that the glucose concentration changes throughout the day. For the mouse the 156 additional stress associated with restraint or anesthesia during blood sampling can add to the 157 variability. In larger species, animals are typically overnight fasted, or even 42 h fasted in some 158 dog studies, to obtain a more consistent baseline glucose concentration. This approach has 159 also been taken by many investigators using mice as their animal model, and it is recommended 160 as standard operating procedure for phenotyping mice by the Eumorphia Consortium (1) 161 (www.eumorphia.org). However the impact of such a long fast on metabolism in the mouse is 162 profound, making extrapolation of those data to observations in the "free living" state difficult.
163
Since mice eat the majority of their food at night and have a very high metabolic rate, overnight 164 fasting a mouse is a major metabolic stress. A lean mouse loses ~15% of its lean body mass 165 after an overnight fast (4). Some Institutional Animal Care and Use Committees do not allow 166 overnight fasting without additional justification. A further complication is that typically mice are 167 housed at ~23°C, which is well below their thermo-neutral zone (~30°C), forcing animals to 168 increase their food intake and energy expenditure to maintain body temperature (14 were moderately obese (7% increase in body weight; body composition was not measured).
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The glucose intolerance observed in obese mice was markedly less pronounced when a fixed 224 dose of glucose was administered compared to when the glucose load was based on body 225 weight (2). Moreover, in contrast to chow fed mice, the glucose excursion in obese mice is very 226 sensitive to the dose of glucose administered, especially when given via the oral route (2). Thus,
227
it is imperative that investigators consider changes in body composition in designing protocols to 228 evaluate glucose tolerance.
229
If body weight and/or fat pad weights differ between groups the investigator should ask 230 whether the conclusion is influenced by the body composition. If glucose tolerance is impaired 231 but fat mass expressed as a fraction of body weight is decreased then repeating the GTT with a 232 fixed dose of glucose may not be needed. In contrast if the investigator suspects that fat mass is 233 increased and glucose tolerance is impaired (with the glucose load based on body weight), then 234 the investigator should consider determining if glucose tolerance is also impaired when a fixed 235 glucose dose is used.
236
The prevailing incoming blood glucose can also complicate the interpretation of a GTT. 
255
given after a fast of variable duration and the glucose concentration is monitored for a much 256 longer duration (~60 to 90 min). For these tests, the fall in blood glucose is used as a reflection 257 of insulin action. In wild type mice on a chow diet glucose concentration falls by ~50%; the 258 depth and rate of the fall can vary depending on the insulin dose. One of the confounding issues 259 with this test is that the prevailing glucose level will influence the rate and magnitude of its fall.
260
In addition, as glucose concentration falls during the ITT, it can activate insulin 261 counterregulation. The glucose threshold for increased counterregulatory hormone release in 262 the mouse is ~ 80 mg/dl (18). This threshold will likely vary depending on a number of factors
263
(e.g. genetic background, nutrition, genetic mutation). A defect in counterregulatory hormone 264 release could be misinterpreted during an ITT as an improvement in insulin action (19).
265
The presence of hyperglycemia at the onset of an ITT could lead to an incorrect
266
"diagnosis" of insulin resistance, depending on how the data are presented. In humans insulin 267 action is estimated by calculating the rate of fall of the log transformed glucose. In contrast in 
275
to 60% in the mouse with the lower blood glucose. Thus the approach of using percent basal to 276 quantify decrements in glucose will underestimate insulin sensitivity in hyperglycemic mice and 277 will inevitably lead to a diagnosis of insulin resistance that may be erroneous.
278
The problem of normalizing glucose dose to body weight during a GTT was discussed in Table 2 for summary of the authors' recommendations).
290
What is the Status of the Glucose Clamp Technique in Application to the Mouse?
291
The hyperinsulinemic, euglycemic clamp technique was first developed for human studies (11) 
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Summary 313
We believe that applying standards for evaluating glucose tolerance and insulin sensitivity 314 is important in the use of genetically-manipulated mice as models of disease. The Eumorphia
315
Consortium (1) recognized that procedures needed to be standardized and adopted
316
(www.eumorphia.org) standards for assessing physiological systems in mice. It has developed 317 such standards for many phenotyping tests. Such standards should be established to define the 318 mouse metabolic phenotype in relation to insulin resistance, diabetes, and obesity. We have 319 made some observations and provided some recommendations based on our experiences, but 320 we recognize that the issues involved are complex. Perhaps our recommendations will serve as 321 an initial iteration from which consensus and standards will form. We welcome comments and 322 hope this article will initiate a discussion of mouse phenotyping practices. 
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Considerations and recommendations are those specified by the authors. 
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